Stock Markets Review

Company: Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories Limited (Dr. Reddy’s) is a global pharmaceutical company. The Company operates in three segments: Pharmaceutical Services and Active Ingredients (PSAI), which includes active pharmaceutical ingredients and intermediaries, which are the principal ingredients for finished pharmaceutical products; Global Generics, which consists of finished pharmaceutical products ready for consumption by the patient, and Proprietary Products, which involves the discovery of new chemical entities for subsequent commercialization and out-licensing. Dr. Reddy’s is vertically integrated and uses its pharmaceutical ingredients and intermediates in its own finished dosage products. The Company conducts basic research mainly in the areas of metabolic disorders, cardiovascular diseases and bacterial infection.

Official website: www.drreddys.com

News
Price targets
Dr. Reddys Laboratories stock recommendation is Neutral by Angel Broking
27 October 2009
Dr. Reddy`s Laboratories (NSE:DRREDDY; BOM:500124) recommendation is "Neutral" by Angel Broking
21 July 2009
New!
Stock Market Forums (US, Europe, Asia)
Free Membership


New!
Stock Market Forums (US, Europe, Asia)
Free Membership


New!
Stock Market Forums (US, Europe, Asia)
Free Membership




Stock Market News: All News | USA News | Indian News | China News
Stock Market Reports: All Stock Reports | USA Stock Market Reports | Indian Stock Market Reports | China Stock Market Reports | Russian Stock Market Reports
Stocks Price Targets: All Stocks | USA Stocks | UK Stocks | Indian Stocks | China Stocks | Russian Stocks
Companies List: All Companies | Dow Jones 30 Companies | S&P 500 Companies | FTSE 100 Companies | DAX 30 Companies | CAC 40 Companies
Archives: Market Reports | News, Analysis & Researches | Price Targets & Recommendations | Commodities | Forex | Global Outlook

About Us | Privacy Policy | Contacts | Links | Contributors